BUY / TP: IDR7,300 (+32.7%)
Entering new phase
• FY18 results: impairment caused a huge drag on earnings
• Revenue grows at a sensible pace
• Stores expansion within plan with additional exclusive brand
• Maintain BUY call with lower target price